A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)
Public ClinicalTrials.gov record NCT02550652. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Obinutuzumab in Patients With ISN/RPS 2003 Class III or IV Lupus Nephritis
Study identification
- NCT ID
- NCT02550652
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 126 participants
Conditions and interventions
Conditions
Interventions
- Mycophenolate Mofetil/Mycophenolic Acid Drug
- Obinutuzumab Drug
- Placebo Other
- Methylprednisolone Drug
- Prednisone Drug
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 12, 2015
- Primary completion
- Jan 14, 2019
- Completion
- Aug 1, 2023
- Last update posted
- Aug 26, 2024
2015 – 2023
United States locations
- U.S. sites
- 7
- U.S. states
- 4
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ of California, San Diego | La Jolla | California | 92093 | — |
| Stanford University Medical Center | Palo Alto | California | 94304 | — |
| Emory Uni ; Division of Rheumatology | Atlanta | Georgia | 30303 | — |
| Suny Downstate Medical Center; Rheumatology | Brooklyn | New York | 11203 | — |
| North Shore - Long Island Jewish Hospital Health System; Rheumatology & Allergy- Clinical Immunology | Great Neck | New York | 11021 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Ohio State University; Division of Nephrology | Columbus | Ohio | 43210 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02550652, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 26, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02550652 live on ClinicalTrials.gov.